Published in Onkologie on April 24, 2012
Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Support Care Cancer (2014) 0.78
Ibandronate: The loading dose concept in the treatment of metastatic bone pain. J Bone Oncol (2015) 0.75
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet (2010) 19.74
Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma (2007) 2.55
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. Lung Cancer (2006) 2.40
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. J Clin Oncol (2012) 1.58
Postoperative radiotherapy in the management of resected non-small-cell lung carcinoma: 10 years' experience in a single institute. Int J Radiat Oncol Biol Phys (2009) 1.46
Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Crit Rev Oncol Hematol (2013) 1.37
Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol (2002) 1.24
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer (2005) 1.12
Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum. Gynecol Oncol (2007) 1.12
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leuk Lymphoma (2009) 1.09
Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer. Ann Nucl Med (2011) 1.02
Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol (2003) 0.99
The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol (2005) 0.97
Multifocal breast cancer in women < or =35 years old. Cancer (2007) 0.95
Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother (2010) 0.95
A case report: zoledronic acid-induced anterior uveitis. Med Oncol (2007) 0.94
Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecol Oncol (2003) 0.93
Breast cancer subtypes and outcomes of central nervous system metastases. Breast (2011) 0.92
Zoledronic acid and atrial fibrillation in cancer patients. Support Care Cancer (2010) 0.92
Low serum leptin level in colon cancer patients without significant weight loss. Tumori (2002) 0.91
Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Eur J Obstet Gynecol Reprod Biol (2009) 0.91
An unusual presentation of extramedullary plasmacytoma in testis and review of the literature. Med Oncol (2009) 0.91
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc (2008) 0.90
Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys (2012) 0.89
The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer. Med Oncol (2007) 0.89
Orbital metastasis from adenocarcinoma of the colon. South Med J (2005) 0.88
Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients. Med Oncol (2008) 0.88
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol (2010) 0.88
Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. J Clin Nurs (2010) 0.87
Modified outpatient dexamethazone, cytarabine and cisplatin regimen may lead to high response rates and low toxicity in lymphoma. Med Princ Pract (2010) 0.87
Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy. Clin Chem Lab Med (2008) 0.87
Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center. Med Oncol (2009) 0.86
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Med Oncol (2013) 0.86
Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer. Cancer Invest (2008) 0.85
Simultaneous presentation of hepatocellular carcinoma in identical twin brothers. Med Oncol (2002) 0.85
Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. Asian Pac J Cancer Prev (2011) 0.85
Primary glioblastoma multiforme in younger patients: a single-institution experience. Tumori (2006) 0.85
Primary granulocytic sarcoma of the urinary bladder: case report and review of the literature. Urology (2002) 0.85
The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. Am J Surg (2011) 0.84
Prognostic factors in localized soft-tissue sarcomas. Am J Clin Oncol (2003) 0.84
Blood ABO groups and risk of breast cancer. Med Oncol (2010) 0.84
Factors affecting the prognosis of breast cancer patients with brain metastases. Breast (2008) 0.84
Patterns of complementary and alternative medicine use among Turkish cancer patients. J Palliat Med (2013) 0.83
Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature. Med Oncol (2009) 0.83
Evaluation of burnout syndrome in oncology employees. Med Oncol (2009) 0.83
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol Oncol (2012) 0.83
Pharmacotherapy of triple-negative breast cancer. Expert Opin Pharmacother (2009) 0.83
Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma. Med Oncol (2006) 0.83
Leptomeningeal dissemination of ovarian carcinoma through a ventriculoperitoneal shunt. Gynecol Oncol (2007) 0.83
Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol (2002) 0.83
Clinical characteristics of gestational trophoblastic disease at a single institute. Tohoku J Exp Med (2002) 0.83
Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation. Nephrol Dial Transplant (2002) 0.82
Malignant ovarian germ cell tumors: a single-institution experience. Am J Clin Oncol (2009) 0.82
Surgery for isolated liver metastasis of ovarian cancer. Asian J Surg (2010) 0.82
A case-control study of non-alcoholic fatty liver disease in breast cancer. Med Oncol (2007) 0.82
Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study. Clin Lung Cancer (2011) 0.81
Good outcomes of patients with stage IB endometrial cancer with surgery alone. Asian Pac J Cancer Prev (2014) 0.81
Clinicopathological features and outcomes of patients with gastric cancer: a single-center experience. World J Gastroenterol (2013) 0.81
Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC). Am J Clin Oncol (2003) 0.81
Postoperative radiotherapy in rectal cancer: long-term results of 290 patients. Hepatogastroenterology (2011) 0.81
"Unfit" for Cisplatin: on basis of which GFR? J Clin Oncol (2011) 0.81
Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines. Breast Cancer Res Treat (2007) 0.80
The status of alternative treatment in cancer patients in Turkey. Cancer Nurs (2005) 0.80
Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy. Medicine (Baltimore) (2016) 0.80
Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer. Ann N Y Acad Sci (2008) 0.79
Two important determinants may play a role in the success of the FinHer Trial. J Clin Oncol (2010) 0.79
Thymoma with chronic diarrhea: report of two cases and review of the literature. Med Oncol (2007) 0.79
Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update. Expert Opin Pharmacother (2014) 0.79
Prophylactic human papilloma virus vaccines for cervical cancer may also prevent development of breast and oropharyngeal cancers in women. Med Hypotheses (2006) 0.79
Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia. JAMA (2008) 0.79
Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study. Am J Clin Oncol (2002) 0.79
Association of breast cancer subtypes and body mass index. Tumori (2013) 0.79
Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis. J Neurooncol (2008) 0.79
Thymidine labeling index: prognostic role in breast cancer. Am J Clin Oncol (2004) 0.79
Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors. Breast Cancer Res Treat (2007) 0.79
Sparing of previously irradiated skin from erlotinib-induced acneiform rash. J Am Acad Dermatol (2008) 0.79
Paraneoplastic pemphigus associated with fludarabine use. Med Oncol (2007) 0.79
Primary diffuse large B cell lymphoma of the breast eight years after the diagnosis of gastric MALT lymphoma: report of first case. Arch Gynecol Obstet (2010) 0.78
Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response. Tumori (2012) 0.78
Prolonged anti-HAV IgM positivity in a pregnant woman. Indian J Gastroenterol (2005) 0.78
Small cell carcinoma of the bladder: a case report and review of the literature. Int Urol Nephrol (2006) 0.78
Clinicopathological features and localization of gastric cancers and their effects on survival in Turkey. Asian Pac J Cancer Prev (2013) 0.78
A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer. Cancer Chemother Pharmacol (2013) 0.77
Factors affecting engraftment time in autologous peripheral stem cell transplantation. Asian Pac J Cancer Prev (2010) 0.77